ArticleBMC gastroenterology2026
Epidemiology and clinical profile of inflammatory bowel disease in Kuwait: a nationwide tertiary care (SEEF-IBD) study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe prevalence of inflammatory bowel disease (IBD) continues to rise globally, with notable shifts in its epidemiological patterns. However, data on characteristics of IBD in Kuwait remain limited. This study aimed to evaluate the demographic and clinical characteristics of IBD in Kuwait.
methodsWe conducted a retrospective cross-sectional study across all 7 tertiary centers in Kuwait. Data was retrieved between November 2025 and December 2025. The primary objective of this study was to report the demographics patterns and phenotypes of IBD in Kuwait. Secondary outcomes were treatment patterns, history of IBD-related surgeries and extraintestinal manifestations (EIM).
resultsA total of 1,944 patients with IBD were included, of whom CD was slightly more common than UC (1,002; 51.5% vs. 894; 46%). Among CD patients, ileocolonic disease (L3) was the predominant phenotype (516; 51.5%), and penetrating disease (B3) accounted for 363 (36.2%). Proportion of male, smoker and younger (< 30 years old) patients was higher in patients with penetrating disease (p < 0.001). In UC, left-sided disease (E2: 390; 43.6%) was the dominant phenotype. Biologics were prescribed in 846 (43.5%) patients. A history of IBD-related surgery was reported in 418 patients (21.5%). EIM were present in 719 patients (37%).
conclusionsThis study provides a comprehensive characterization of the demographic patterns of IBD in Kuwait, highlighting a higher prevalence of CD, particularly penetrating phenotypes among younger male patients. These findings reflect the evolving burden of IBD in the Middle East and reinforce the importance of timely diagnosis and ensuring access to effective, targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.